Cardiovascular Safety of Naproxen for Treating Cancer and Noncancer Chronic Pain.
作者信息
Nair Abhijit S
机构信息
Department of Anesthesiology and Pain Management, Basavatarakam Indo-American Cancer Hospital and Research Institute, Hyderabad, Telangana, India.
出版信息
Indian J Palliat Care. 2019 Jan-Mar;25(1):164-165. doi: 10.4103/IJPC.IJPC_143_18.
Abstract
摘要
相似文献
1
Cardiovascular Safety of Naproxen for Treating Cancer and Noncancer Chronic Pain.萘普生治疗癌症和非癌症慢性疼痛的心血管安全性
Indian J Palliat Care. 2019 Jan-Mar;25(1):164-165. doi: 10.4103/IJPC.IJPC_143_18.
2
Changing residents' beliefs and concerns about treating chronic noncancer pain with opioids: evaluation of a pilot workshop.改变住院医师对使用阿片类药物治疗慢性非癌性疼痛的观念和担忧：一项试点研讨会的评估
Pain Med. 2008 Oct;9(7):890-902. doi: 10.1111/j.1526-4637.2008.00458.x. Epub 2008 Jun 18.
3
Cardiorenal Safety of OTC Analgesics.非处方镇痛药的心脏肾脏安全性。
J Cardiovasc Pharmacol Ther. 2018 Mar;23(2):103-118. doi: 10.1177/1074248417751070.
4
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.塞来昔布综合安全性与布洛芬或萘普生前瞻性随机评估（PRECISION）的原理、设计与管理，一项针对关节炎患者的非甾体抗炎药心血管终点试验。
Am Heart J. 2009 Apr;157(4):606-12. doi: 10.1016/j.ahj.2008.12.014. Epub 2009 Feb 25.
5
Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain.盐酸替扎尼定治疗慢性腰痛的疗效和安全性与萘普生的比较。
Pain. 2013 Jul;154(7):1009-21. doi: 10.1016/j.pain.2013.03.006. Epub 2013 Mar 14.
6
Opioid Prescription in Switzerland: Appropriate Comedication use in Cancer and Noncancer Pain.瑞士的阿片类药物处方：癌症和非癌症疼痛的适当合并用药。
Pain Physician. 2019 Nov;22(6):537-548.
7
Opioid therapy for chronic noncancer back pain. A randomized prospective study.阿片类药物治疗慢性非癌性背痛。一项随机前瞻性研究。
Spine (Phila Pa 1976). 1998 Dec 1;23(23):2591-600. doi: 10.1097/00007632-199812010-00014.
8
Suicidality in chronic noncancer pain patients.慢性非癌痛患者的自杀倾向。
Int J Neurosci. 2009;119(10):1968-79. doi: 10.1080/00207450902973336.
9
NSAIDs relieve osteoarthritis (OA) pain, but cardiovascular safety in question even for diclofenac, ibuprofen, naproxen, and celecoxib: what are the alternatives?非甾体抗炎药可缓解骨关节炎（OA）疼痛，但即便对于双氯芬酸、布洛芬、萘普生和塞来昔布而言，其心血管安全性也存在疑问：有哪些替代药物呢？
Scand J Pain. 2017 Jul;16:148-149. doi: 10.1016/j.sjpain.2017.05.009. Epub 2017 Jun 15.
10
Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, part 2: impact on function, mood, and quality of life.社区居住的癌症疼痛和非癌症疼痛患者的突破性疼痛，第2部分：对功能、情绪和生活质量的影响。
J Opioid Manag. 2010 Mar-Apr;6(2):109-16. doi: 10.5055/jom.2010.0010.
本文引用的文献
1
Cardiovascular Safety of Celecoxib, Naproxen, or Ibuprofen for Arthritis.塞来昔布、萘普生或布洛芬治疗关节炎的心血管安全性。
N Engl J Med. 2016 Dec 29;375(26):2519-29. doi: 10.1056/NEJMoa1611593. Epub 2016 Nov 13.
2
Clinical Pharmacology and Cardiovascular Safety of Naproxen.萘普生的临床药理学与心血管安全性
Am J Cardiovasc Drugs. 2017 Apr;17(2):97-107. doi: 10.1007/s40256-016-0200-5.
3
Cardiovascular safety of NSAIDs.非甾体抗炎药的心血管安全性。
Can Fam Physician. 2014 Mar;60(3):e166.
4
The World Health Organization analgesic ladder.世界卫生组织镇痛阶梯。
J Midwifery Womens Health. 2004 Nov-Dec;49(6):542-5. doi: 10.1016/j.jmwh.2004.08.021.
5
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.罗非昔布与萘普生对类风湿关节炎患者上消化道毒性的比较。VIGOR研究组。
N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528. doi: 10.1056/NEJM200011233432103.
Zotero 插件